For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Sequus Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 15

Trademarks = 1

Forward Citations = 1,162

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Francis J Martin (11 out of 55 patents)

Samuel Zalipsky (9 out of 43 patents)

Martin C Woodle (4 out of 13 patents)

4. Shi Kun Huang (3 out of 19 patents)

5. Theresa M Allen (3 out of 16 patents)

6. Yechezkel Barenholz (2 out of 60 patents)

7. Bei Jin (2 out of 3 patents)

8. Edwin Kiyoshi Oto (2 out of 2 patents)

9. Mohammad Hassanipour (2 out of 2 patents)

10. Karen Reis (2 out of 2 patents)

11. Robert M Abra (2 out of 12 patents)

12. Paul S Uster (2 out of 6 patents)

13. Danilo D Lasic (1 out of 5 patents)

14. Irma Ajm Bakker-Woudenberg (1 out of 1 patent)

15. Josh Gittelman (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 6326353 - Enhanced circulation effector composition and method (2001-12-04),

2. 6316024 - Therapeutic liposome composition and method of preparation (2001-11-13),

3. 6224903 - Polymer-lipid conjugate for fusion of target membranes (2001-05-01),

4. 6180134 - Enhanced ciruclation effector composition and method (2001-01-30),

5. 6133026 - Condensed plasmid-liposome complex for transfection (2000-10-17),

6. 6126966 - Liposomes containing a cisplatin compound (2000-10-03),

7. 6056973 - Therapeutic liposome composition and method of preparation (2000-05-02),

8. 6043094 - Therapeutic liposome composition and method (2000-03-28),

9. 5972379 - Liposome composition and method for administering a quinolone (1999-10-26),

10. 5945122 - Liposomes containing a cisplatin compound (1999-08-31),

11. 5891468 - Fusogenic liposome compositions and method (1999-04-06),

12. 5851818 - Condensed plasmid-liposome complex for transfection (1998-12-22),

13. 5843473 - Method of treatment of infected tissues (1998-12-01),

14. 5631018 - Lipid-polymer conjugates and liposomes (1997-05-20),

15. 5527528 - Solid-tumor treatment method (1996-06-18),

Company Overview

Sequus Pharmaceuticals, Inc. is a biopharmaceutical company based in Menlo Park, California, specializing in the development of innovative drug delivery systems. The company focuses on creating advanced formulations and technologies to enhance the therapeutic efficacy of existing drugs, particularly in oncology and other critical therapeutic areas. By leveraging proprietary delivery mechanisms, Sequus aims to improve patient outcomes and expand the potential of established medications, contributing to the evolving landscape of pharmaceutical therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

15 Patents

#95 in Menlo Park, CA

#5,037 in California

#21,085 in US

#39,991 in the World

Menlo Park, CA, United States of America

Sequus Pharmaceuticals, Inc.

Forward Citations = 1,162

16 inventors:

Francis J Martin (11 out of 55 patents)

Samuel Zalipsky (9 out of 43 patents)

Martin C Woodle (4 out of 13 patents)

4. Shi Kun Huang (3 out of 19 patents)

5. Theresa M Allen (3 out of 16 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sequus Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/sequus-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…